Table 2.
Eligibility screening | Days 1–180 |
Every 6 months through year 5 | Every 12 months through year 5 | Every 12 months through years 5–7 | |||
Tests and observations | History and physical | X | Registration | X | X | ||
Weight, height | X | ||||||
Pulse, blood pressure | X | ||||||
Randomisation | X | ||||||
Imaging studies β | Contralateral MMG | X | |||||
Ipsilateral breast imaging | Xγ | X (AS only) |
X (GCC only) |
||||
Bilateral MMG | Xγ | X | |||||
Therapeutic procedures | Surgery | X (GCC only) |
|||||
Radiation | X (GCC only) |
||||||
Discussion regarding endocrine therapy. Initiation if patient opts for treatment | X |
AS, active surveillance; GCC, guideline concordant care; MMG, mammogram.